# Safety of REPEVAX® Given One Month After REVAXIS®

> **NCT00400309** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 500 (actual)

## Conditions studied

- Healthy Adult

## Interventions

- **BIOLOGICAL:** REPEVAX® after REVAXIS®
- **BIOLOGICAL:** REPEVAX® after Placebo

## Key facts

- **NCT ID:** NCT00400309
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2017-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00400309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00400309, "Safety of REPEVAX® Given One Month After REVAXIS®". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00400309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*